Saltide HFA 25/250 Inhaler is a combination medication used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It combines a long-acting beta-2 agonist (Salmeterol) and an inhaled corticosteroid (Fluticasone), providing both bronchodilation and anti-inflammatory effects.
This combination therapy is designed for long-term control of symptoms, improving lung function, and reducing the frequency of asthma attacks or COPD exacerbations. It is not intended for acute relief of bronchospasm.